ACMP up +1.93% percent right now. $ACMP High is at 63.20

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
ACMP up +1.93% percent right now. $ACMP High is at 63.20 and the Low 61.77 with current volume of 651,800.

Recent News posted below.

ACMP Access Midstream Partners L.P. Recent Headline News

Jordan Cove LNG and Pacific Connector Gas Pipeline Receive Draft Environmental Impact Statement
Business Wire - Fri Nov 07, 9:22AM CST
Jordan Cove Energy Project L.P. ("Jordan Cove LNG" and Pacific Connector Gas Pipeline, LP ("Pacific Connector" have today received a draft Environmental Impact Statement ("EIS" from the Federal Energy Regulatory Commission ("FERC". The draft EIS assesses the environmental impacts of the liquefied natural gas ("LNG" terminal proposed by Jordan Cove LNG for Coos Bay, Oregon and the natural gas pipeline proposed by Pacific Connector that would extend 232 miles from Malin, Oregon to the terminal. Jordan Cove LNG and Pacific Connector each filed an application with the FERC for approval to construct the LNG export terminal and the pipeline in May and June 2013, respectively.
ACMP: 62.89 (+1.19), WMB: 55.38 (+0.67), WPZ: 52.48 (+0.72), VSN.TO: 17.99 (+0.63)

Williams, Williams Partners L.P. and Access Midstream Partners, L.P. to Present at Jefferies 2014 Global Energy Conference
Business Wire - Wed Nov 05, 3:06PM CST
Don Chappel, a senior executive of Williams (NYSE: WMB), Williams Partners L.P. (NYSE: WPZ) and Access Midstream Partners, L.P. (NYSE: ACMP), is scheduled to present at the Jefferies 2014 Global Energy Conference Wednesday, Nov. 12, at approximately 11:30 a.m. CST.
ACMP: 62.89 (+1.19), WMB: 55.38 (+0.67), WPZ: 52.48 (+0.72)

ONEOK Partners (OKS) Beats on Q3 Earnings, Down Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 9:40AM CST
In the third quarter of 2014, ONEOK Partners, L.P.'s (OKS) earnings per unit surpassed the Zacks Consensus Estimate while revenues missed the same.
ACMP: 62.89 (+1.19), OKS: 48.41 (+0.64), MMP: 84.51 (+0.30), EPD: 37.62 (+1.05)

WILLIAMS PARTNERS INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Williams Partners LP Over the Proposed Sale of the Company to Access Midstream Partners LP
PR Newswire - Fri Oct 31, 6:20PM CDT
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Williams Partners LP ("Williams Partners" or the "Company" (NYSE: WPZ) for potential breaches of fiduciary duties in connection with the sale of the Company to Access Midstream Partners for approximately $50 billion. The Company's unitholders will only receive 0.86672 common units of Access Midstream for each unit of Williams Partners they own.
ACMP: 62.89 (+1.19), WPZ: 52.48 (+0.72)

Zacks Rank #1 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
ACPW: 1.89 (+0.01), ACMP: 62.89 (+1.19), AMAG: 34.95 (+0.83), AMED: 24.79 (-0.38), ACCO: 8.55 (unch)

Why Hercules Offshore (HERO) Could Be Positioned for a Slump - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 7:57AM CDT
Hercules Offshore stock could bring additional losses for your portfolio
HERO: 1.74 (+0.23), ACMP: 62.89 (+1.19), MMP: 84.51 (+0.30), CIE: 10.98 (+0.36)

Williams Companies Earnings: Do Plunging Earnings Mean You Should Sell?
Adam Galas, The Motley Fool - Motley Fool - Wed Oct 29, 10:28PM CDT
Williams Companies has traversed a rocky road over the past year. Its MLP, Williams Partners , has faced quarter after quarter of declining revenue and has failed to cover its fast-growing distribution. It has also now missed earnings for four...
ACMP: 62.89 (+1.19), WMB: 55.38 (+0.67), WPZ: 52.48 (+0.72)

Williams Partners Reports Third-Quarter 2014 Financial Results
Business Wire - Wed Oct 29, 3:16PM CDT
--Geismar Plant Startup in November Consistent With Previous Guidance
ACMP: 62.89 (+1.19), WMB: 55.38 (+0.67), WPZ: 52.48 (+0.72)

Williams Reports Third-Quarter 2014 Financial Results
Business Wire - Wed Oct 29, 3:16PM CDT
--3Q 2014 Net Income is $1.678 Billion or $2.22 per Share; Driven Primarily by Gain Related to Revaluation of Access Midstream Interests
ACMP: 62.89 (+1.19), WMB: 55.38 (+0.67), WPZ: 52.48 (+0.72)

Access Midstream Partners, L.P. Reports Financial Results for the 2014 Third Quarter
Business Wire - Wed Oct 29, 3:15PM CDT
--Partnership Increases Quarterly Distribution to $0.615 per Unit
ACMP: 62.89 (+1.19), WMB: 55.38 (+0.67), WPZ: 52.48 (+0.72)

Stock Market Crash: 4 High-Yield Dividend Stocks You Can Buy Today
Adam Galas, The Motley Fool - Motley Fool - Wed Oct 29, 11:15AM CDT
In recent weeks the S&P 500 has plunged as much as 7.5% off its recent highs and the volatility index, a sign of investor fear, has soared.  ^SPX data by YCharts Many investors are concerned that we may be on the verge of a correction...
KMI: 38.75 (+0.22), EPB: 40.91 (+0.15), MAIN: 32.27 (+0.72), ACMP: 62.89 (+1.19), KMR: 95.58 (+0.54), KMP: 94.73 (+0.23), WMB: 55.38 (+0.67), WPZ: 52.48 (+0.72)

NYSE stocks posting largest volume increases
AP - Tue Oct 28, 5:14PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:
TEN: 53.31 (-0.69), MOG.B: 75.38 (unch), MSM: 83.65 (-0.14), MOG.A: 74.54 (-0.93), JMP: 7.83 (-0.15), ACMP: 62.89 (+1.19), TRMR: 2.28 (+0.05), CQB: 14.43 (+0.01), HVB: 25.69 (+0.21), RGC: 22.15 (-0.07)

NYSE stocks posting largest percentage increases
AP - Tue Oct 28, 12:26PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at 1 p.m.:
OMN: 7.39 (+0.06), JONE: 13.54 (+1.71), ACMP: 62.89 (+1.19), CLV: 10.77 (+0.44), BBW: 17.78 (-0.61), EVDY: 12.69 (-0.08), WTI: 9.31 (+0.70), CLF: 11.17 (+0.63), SPA: 25.70 (-0.31), MTW: 21.13 (+0.16), W: 26.01 (+0.31), IVC: 15.80 (-0.57), JMP: 7.83 (-0.15), NM: 6.01 (+0.15), IMPV: 42.53 (+0.87), GNI: 21.62 (+1.07)

EQUITY ALERT: Rosen Law Firm Announces Investigation of Williams Partners L.P. Concerning its Proposed Sale to Access Midstream Partners, L.P. - WPZ
Business Wire - Tue Oct 28, 11:33AM CDT
The Rosen Law Firm, P.A. announces that it is investigating the Board of Directors of Williams Partners L.P. (NYSE: WPZ) for possible breaches of fiduciary duty and other violations of law by failing to adequately shop Williams Partners to maximize shareholder value before agreeing to be acquired by Midstream Partners, L.P. (NYSE: ACMP).
ACMP: 62.89 (+1.19), WPZ: 52.48 (+0.72)

Wolf Popper LLP Investigates Claims That the Proposed Acquisition of Williams Partners, L.P. May Not Be in Its Investors Best Interests
PR Newswire - Tue Oct 28, 8:50AM CDT
Wolf Popper LLP is investigating claims on behalf of investors in Williams Partners, L.P. (NYSE: WPZ), concerning the proposed acquisition of Williams by Access Midstream Partners, L.P. (NYSE: ACMP). Williams' unitholders seeking more information about this acquisition are advised to contact Carl Stine at (212) 759-4600 or cstine@wolfpopper.com.
ACMP: 62.89 (+1.19), WPZ: 52.48 (+0.72)

Access Midstream Partners, L.P. Increases Distribution To $0.615 Per Unit for The 2014 Third Quarter
Business Wire - Tue Oct 28, 7:31AM CDT
Access Midstream Partners, L.P. (NYSE:ACMP), today announced that the Board of Directors of its general partner declared a cash distribution of $0.615 per Common Unit for the 2014 third quarter. The third quarter cash distribution represents an increase of $0.08, or 15.0%, compared to the 2013 third quarter and represents an increase of $0.02, or 3.4%, compared to the 2014 second quarter.
ACMP: 62.89 (+1.19)

5 Stocks Rising on Unusual Volume
at The Street - Tue Oct 28, 6:00AM CDT
Often when above-average volume moves into an equity, it precedes a large spike in volatility.
LVLT: 45.85 (-0.51), ACMP: 62.89 (+1.19), GSIG: 12.82 (unch), SCOR: 42.92 (-0.06), WPZ: 52.48 (+0.72)

Will Access Midstream (ACMP) Miss Q3 Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 5:30PM CDT
Access Midstream Partners (ACMP) is slated to report its third-quarter results on Oct 29, 2014; is it poised to beat earnings?
ACMP: 62.89 (+1.19), WMB: 55.38 (+0.67), WPZ: 52.48 (+0.72), DKL: 40.34 (+0.15)

Williams Cos. Sweetens Terms for MLPs' $50 Billion Merger
at The Street - Mon Oct 27, 10:43AM CDT
The deal moves the gas company closer to a pure play general partner holding company.
KMI: 38.75 (+0.22), QEP: 25.87 (+0.32), ATLS: 37.32 (+1.48), OILT: 44.80 (+0.77), APL: 34.47 (+0.47), ACMP: 62.89 (+1.19), NGLS: 58.93 (+0.46), TRGP: 120.16 (+1.74), WMB: 55.38 (+0.67), TLLP: 57.73 (+0.80), WPZ: 52.48 (+0.72), EPD: 37.62 (+1.05)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 75

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 176

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 324

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 90

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 345

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 209

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Earnings Forecast and Expectations for Anika Therapeutics

Updated Category News Views 118

Understanding Anika Therapeutics's Upcoming Earnings Anika Therapeutics (NASDAQ: ANIK) is scheduled to unveil its quarterly earnings report soon. This anticipation is palpable amongst investors who are eager to discover the latest financial insights that the company has to offer. As the date approaches, many are analyzing the potential earnings and what they might mean...

Continue Reading
QYOU Media's Strategic Shift Towards a Creator-Focused Future

Updated Category News Views 202

QYOU Media Completes Sale of Q TV Broadcast Channel QYOU Media Inc., a leading player in the global creator economy, has successfully completed the sale of its free-to-air broadcast channel known as Q TV. This strategic move, executed through its subsidiary QYOU Media India Pvt. Ltd., marks a significant shift towards embracing new growth avenues focused on social media...

Continue Reading
Understanding Recent Disclosures from Octopus Investments

Updated Category News Views 106

Key Disclosure Information by Octopus Investments PUBLIC DISCLOSURE OF INVESTMENT INTERESTS In line with market regulations, Octopus Investments Ltd reveals crucial data regarding interests in relevant securities, particularly concerning Marlowe plc. This disclosure adheres to Rule 8.3 of the Takeover Code, aimed at maintaining transparency in the investment community....

Continue Reading
LiTime's Innovative Battery Solutions Shine in European RV Market

Updated Category News Views 297

LiTime Introduces H190 Series Batteries for RV Enthusiasts At a recent trade show, LiTime made quite the impression with its first participation in Europe’s premier RV exhibition, the Il Salone del Camper. The event, which boasts a large turnout, allowed the company to spotlight its innovative H190 series of batteries tailored for motorhomes. Targeted Designs for Unique...

Continue Reading
Oncolytics Biotech Appoints Jared Kelly as New CEO to Lead Growth

Updated Category News Views 263

Oncolytics Biotech Welcomes New Leadership for Future Growth Oncolytics Biotech Inc. (NASDAQ: ONCY), a notable player in the clinical-stage biotechnology sector focused on immunotherapy for cancer treatment, has proudly appointed Jared Kelly as its new Chief Executive Officer and as a member of its Board of Directors. This significant transition marks a pivotal moment for...

Continue Reading